Insider Transactions in Q3 2025 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
14,000
-1.65%
|
$84,000
$6.36 P/Share
|
|
Sep 12
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+1.63%
|
$28,000
$2.39 P/Share
|
|
Sep 12
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,706
-53.35%
|
$52,236
$6.44 P/Share
|
|
Sep 12
2025
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,706
+34.79%
|
$8,706
$1.37 P/Share
|
|
Jul 21
2025
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,000
+1.52%
|
$2,000
$2.92 P/Share
|
|
Jul 17
2025
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
5,000
+9.13%
|
$10,000
$2.9 P/Share
|